Shannon Thyme Klinger, Chief Legal Officer at Moderna, Inc. (MRNA), sold 10,356 shares at $148.09 ($1.5M) on 2024-06-10, disclosed to the SEC on 2024-06-11.
Scheduled sale ($1.5M) by Chief Legal Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $148.09 | 5,178 | $767K | 50.0% |
| 2 | $148.09 | 5,178 | $767K | 50.0% |
| Total | $148.09 avg | 10,356 | $1.5M | 100% |
| Filing → |
| MRNA | SELL | 2026-03-03 | $726K | — | Filing → |
| MRNA | SELL | 2024-12-10 | $24K | — | Filing → |
| MRNA | SELL | 2024-12-04 | $5K | — | Filing → |